GPX4 and breast carcinoma: MDA-MB-231 cells lacking GPX4 was found more sensitive to HYP PDT than the MCF7 cells and has previously been reported to be most sensitive to TPCS2a-PDT of 4 breast cancer cell lines [4a] .